Last analyzed: May 28, 2026 (Q4 FY25)

Novartis AG

NVS

Pharmaceuticals

$151.40

Market Cap

$289M

P/E Ratio

21.604586

Revenue Rank

Rank 4

Margin Rank

Rank 3

Performance Parameter: Indicating Future Growth(Based on Quarterly Earnings Call)

Explore More Tools

Discover more ways to research and analyze Indian stocks

Stock RankingsAI-ranked stocks from earnings callsStock ScreenerFilter by P/E, ROE, growth & moreIPO DashboardUpcoming, open & listed IPOsCompare StocksSide-by-side stock comparisonCalculatorsSIP, CAGR, EMI & moreEarnings CalendarUpcoming earnings callsAnalyze PortfolioAI health check for your portfolioBlogMarket insights & guides